Health Desk

Novo Nordisk Alzheimer drug trial fails to meet main goal

Copenhagen: Novo Nordisk has announced that its major Alzheimer drug trial has failed to meet its main target, dealing a blow to hopes that the company’s widely used diabetes and obesity med...

Read More